Category Archives: Uncategorized

FOR IMMEDIATE RELEASE LOS ANGELES, CA and BUFFALO, NY (BUSINESS WIRE) — Empire Genomics, a Biocare Medical company, and Molecular Instruments® (MI), founded by the inventor of HCR™ technology, today launched NISH (Neo in situ hybridization) — the largest ready-to-use, fully automated ISH library for research – exclusively available worldwide on the NeoPATH Pro automated […]

April 29, 2026 Empire Genomics is Now Serving Canada Directly Dear Valued Customer, To better support your clinical and research objectives, Empire Genomics has transitioned to a direct sales and support model within Canada. We are moving away from our previous third-party distribution structure to establish a closer, more integrated relationship with our Canadian partners. […]

IVDR Status Update – What This Means for You Empire Genomics is moving full speed ahead in our transition to EU IVDR (Regulation (EU) 2017/746)—and we’re excited to share our progress with you. We are currently finalizing and preparing the submission of our IVDR technical documentation, with submissions targeted for completion by the end of Q1 2026. These […]

Empire Genomics’ IVDR Transition Is Underway Empire Genomics is proud to share that we have officially implemented a strategic plan to bring our product portfolio into full compliance with Regulation (EU) 2017/746 (IVDR). This transition is a major milestone in our continued commitment to product quality, patient safety, and uninterrupted access to high-performing genomic solutions […]

Dear Valued Customer, In celebration of the recent court ruling reaffirming labs’ autonomy in developing their diagnostic tests, Empire Genomics is excited to announce our special “Labs Deciding Tests (LDT)” Promotion! To empower your lab’s validation process with every NEW FISH probe order, we’re offering: FREE SwiftFISH (Rapid Buffer) FREE Wash Buffer FREE DAPI This […]